Comparative Study
doi: 10.5301/ijbm.5000272.
Circulating tumor markers: a guide to their appropriate clinical use | Comparative summary of recommendations from clinical practice guidelines (PART 3)
Affiliations
- PMID: 28475208
- DOI: 10.5301/ijbm.5000272
Item in Clipboard
Comparative Study
Circulating tumor markers: a guide to their appropriate clinical use | Comparative summary of recommendations from clinical practice guidelines (PART 3)
Int J Biol Markers.
.
Free article
No abstract available
Similar articles
-
Circulating tumor markers: a guide to their appropriate clinical use | Comparative summary of recommendations from clinical practice guidelines (PART 2).Int J Biol Markers. 2017 Mar 2;32(1):e1-e52. doi: 10.5301/ijbm.5000259. Int J Biol Markers. 2017. PMID: 28255982 No abstract available.
-
Circulating tumor markers: a guide to their appropriate clinical use | Comparative summary of recommendations from clinical practice guidelines (PART 1).Int J Biol Markers. 2016 Dec 23;31(4):e332-e367. doi: 10.5301/jbm.5000251. Int J Biol Markers. 2016. PMID: 28025819 No abstract available.
-
Erratum to: Circulating tumor markers: a guide to their appropriate clinical use | Comparative summary of recommendations from clinical practice guidelines (PART 1), (PART 2), (PART 3).Int J Biol Markers. 2017 Oct 31;32(4):e478. doi: 10.5301/JBM.2017.17614. Int J Biol Markers. 2017. PMID: 29048700
-
Practice guidelines for tumor marker use in the clinic.Clin Chem. 2002 Aug;48(8):1151-9. Clin Chem. 2002. PMID: 12142367 Review.
-
Circulating tumour cells and circulating endothelial cells as biomarkers in oncology.Acta Clin Belg. 2011 Sep-Oct;66(5):332-6. doi: 10.2143/ACB.66.5.2062584. Acta Clin Belg. 2011. PMID: 22145267 Review.
Cited by
-
Insufficient uptake of systematic search methods in oncological clinical practice guideline: a systematic review.BMC Med Res Methodol. 2019 Aug 20;19(1):180. doi: 10.1186/s12874-019-0818-5. BMC Med Res Methodol. 2019. PMID: 31429714 Free PMC article.
-
Appropriateness of tumor marker request: a case of study.Ann Transl Med. 2017 Jul;5(13):274. doi: 10.21037/atm.2017.06.19. Ann Transl Med. 2017. PMID: 28758100 Free PMC article.
-
Serum Tumor Markers in Paraneoplastic Neurologic Syndromes: A Systematic Review of Guidelines.Front Neurol. 2021 Jan 18;11:607553. doi: 10.3389/fneur.2020.607553. eCollection 2020. Front Neurol. 2021. PMID: 33536995 Free PMC article.
-
Are Tumor Marker Tests Applied Appropriately in Clinical Practice? A Healthcare Claims Data Analysis.Diagnostics (Basel). 2023 Nov 3;13(21):3379. doi: 10.3390/diagnostics13213379. Diagnostics (Basel). 2023. PMID: 37958275 Free PMC article.
-
Relevance of blood tumor markers in inpatients with significant involuntary weight loss and elevated levels of inflammation biomarkers.BMC Cancer. 2024 Apr 15;24(1):468. doi: 10.1186/s12885-024-12201-0. BMC Cancer. 2024. PMID: 38622530 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
